Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Respiratory sarcopenia and prehabilitation in thoracic oncology: Diagnostic approaches and clinical implications | Synapse
March 3, 2026
Respiratory sarcopenia and prehabilitation in thoracic oncology: Diagnostic approaches and clinical implications
DD
David Dávila-Dupont
MA
Marisol Arroyo-Hernández
Instituto Nacional de Cancerología
JT
Jenny G. Turcott
Ver todo
Puntos clave
Respiratory sarcopenia significantly impacts treatment outcomes in thoracic oncology patients, highlighting its importance.
Prehabilitation improves physical fitness and recovery, with evidence suggesting benefits across varied patient profiles.
Observational analysis across various centers indicates the need for enhanced diagnostic approaches to identify respiratory sarcopenia.
The findings suggest prehabilitation could enable better outcomes; however, external validation is necessary.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Dávila-Dupont et al. (Sun,) studied this question.
synapsesocial.com/papers/69a76586badf0bb9e87d96b8
https://doi.org/https://doi.org/10.1016/j.lungcan.2026.108949